May 25, 2019
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Bimatoprost SR shows long-term IOP lowering
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, E. Randy Craven, MD, discusses a study looking at the long-term IOP-lowering effects of Bimatoprost SR (Allergan) in patients with glaucoma.